Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riederer

Showing results (181-190 of 587) with videos related to

Pageof 59
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|August 12, 1999
Parkinson's disease: a major hypokinetic basal ganglia disorderJ Sian, M Gerlach, M B Youdim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 27, 2005
Central administration of alloxan impairs glucose tolerance in ratsM Salkovic-Petrisic, Z Lackovic, S Hoyer, et al.
British Journal of Pharmacology|November 1, 1976
L-dopa and (-)-deprenil in the treatment of Parkinson's disease: a long-term study [proceedings]L Ambrozi, W Birkmayer, P Riederer, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1983
(-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's diseaseW Birkmayer, J Knoll, P Riederer, et al.
Metabolic Brain Disease|March 1, 1989
Biochemical events in spontaneous seizures in the Mongolian gerbilR Wolf-Dieter, G Heuschneider, G Sperk, et al.
Advances in Experimental Medicine and Biology|January 5, 2002
A sensitive procedure for the determination of protein bound 3,4-dihydroxyphenyl-alanine as a marker for posttranslational protein hydroxylation in human frontal cortex, liver, and red blood cellsR Harth, M Gerlach, P Riederer, et al.
Biogerontology|November 16, 2001
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?S Dukic-Stefanovic, R Schinzel, P Riederer, et al.
Journal of Neural Transmission|January 1, 1975
The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, DeprenilW Birkmayer, P Riederer, M B Youdim, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Interaction of neuroprotective substances with human brain superoxide dismutase. An in vitro studyW Gsell, N Reichert, M B Youdim, et al.
Advances in Neurology|July 20, 1999
Nitric oxide in the pathogenesis of Parkinson's diseaseM Gerlach, D Blum-Degen, J Lan, et al.
Pageof 59

Showing results (181-190 of 587) with videos related to

Sort By:
Pageof 59
Journal of Neural Transmission (Vienna, Austria : 1996)|August 12, 1999
Parkinson's disease: a major hypokinetic basal ganglia disorderJ Sian, M Gerlach, M B Youdim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 27, 2005
Central administration of alloxan impairs glucose tolerance in ratsM Salkovic-Petrisic, Z Lackovic, S Hoyer, et al.
British Journal of Pharmacology|November 1, 1976
L-dopa and (-)-deprenil in the treatment of Parkinson's disease: a long-term study [proceedings]L Ambrozi, W Birkmayer, P Riederer, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1983
(-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's diseaseW Birkmayer, J Knoll, P Riederer, et al.
Metabolic Brain Disease|March 1, 1989
Biochemical events in spontaneous seizures in the Mongolian gerbilR Wolf-Dieter, G Heuschneider, G Sperk, et al.
Advances in Experimental Medicine and Biology|January 5, 2002
A sensitive procedure for the determination of protein bound 3,4-dihydroxyphenyl-alanine as a marker for posttranslational protein hydroxylation in human frontal cortex, liver, and red blood cellsR Harth, M Gerlach, P Riederer, et al.
Biogerontology|November 16, 2001
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?S Dukic-Stefanovic, R Schinzel, P Riederer, et al.
Journal of Neural Transmission|January 1, 1975
The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, DeprenilW Birkmayer, P Riederer, M B Youdim, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Interaction of neuroprotective substances with human brain superoxide dismutase. An in vitro studyW Gsell, N Reichert, M B Youdim, et al.
Advances in Neurology|July 20, 1999
Nitric oxide in the pathogenesis of Parkinson's diseaseM Gerlach, D Blum-Degen, J Lan, et al.
Pageof 59